Key Offerings To Help Support Your OSD On Its Journey To Market

The production of oral solid dosage (OSD) forms is becoming increasingly complex as innovative techniques and technologies make it easier to harness challenging active pharmaceutical ingredients (APIs) in new medicines. As a result, the pathway from early clinical phases to the commercial market for these revolutionary therapeutics is not always straightforward.

At Pfizer CentreOne, making the complex simple to meet your OSD needs is our specialty. Utilizing our global Pfizer network, we leverage our state-of-the-art facilities and decades of experience in successfully delivering high-quality OSD products — including highly potent, cytotoxic, controlled, and immunosuppressant drugs — to support even the most complex OSD needs.

In this article, we examine the key offerings a reliable CDMO partner must provide to successfully help support your OSD on its journey to market. We also explore how Pfizer CentreOne can help.